AstraZeneca looking to roll out jab for new Covid-19 variants by Autumn

11 February 2021, 14:25

AstraZeneca hopes to roll out a vaccine that is effective against new variants by May
AstraZeneca hopes to roll out a vaccine that is effective against new variants by May. Picture: PA

By Maddie Goodfellow

A coronavirus vaccine that is effective against new variants could be rolled out by the Autumn, AstraZeneca has said.

The pharmaceuticals giant, which has produced a Covid vaccine in conjuncture with the University of Oxford, said clinical trials of a jab for variants would be starting this Spring.

The company also said that the current plan would be to start mass producing the new jab in six to nine months.

AstraZeneca chief executive Pascal Soriot said there should be a drop in hospital admissions "very soon" as the effects of the UK's vaccine rollout start to be seen.

Mr Soriot said: "100 million doses in February means 100 million vaccinations, which means hundreds of thousands of severe infections avoided and it also means thousands of deaths that are avoided."

Read more: One third of all Covid-19 patients in England's hospitals admitted in January 2021 alone

Read more: Kent Covid-19 variant 'to become world's dominant strain'

Virologist explains why Kent variant is 'on course to sweep the world'

"We're going to save thousands of lives and that's why we come to work every day as individuals," he added.

"Is it perfect? No it's not perfect, but it's great. Who else is making 100 million doses in February?"

AstraZeneca is on course to deliver 100 million doses around the world this month, with the company hoping to double this to 200 million a month by April.

Read more: SAGE scientist predicts UK should be 'more or less' free of Covid crisis by end of 2021

Read more: Plans for more integration of NHS and social care to 'cut bureaucracy'

Patrick Vallance urges people to get vaccine even if they've had Covid

It comes after the news that the Oxford/AstraZeneca vaccine offers only limited protection against mild disease caused by the South African variant of coronavirus, according to research.

The news prompted South Africa to suspend its rollout of the jab.

But the company said early data from the study has shown the jab can protect against severe disease caused by the mutation.

The study, first reported by the Financial Times, into the E484K mutation involved some 2,000 people, most of whom were young and healthy.

"We do believe our vaccine could protect against severe disease, as neutralising antibody activity is equivalent to that of other Covid-19 vaccines that have demonstrated activity against more severe disease, particularly when the dosing interval is optimised to eight to 12 weeks," a spokesman reportedly said.

Earlier research indicated that the Oxford/AstraZeneca jab is effective at fighting the new UK coronavirus variant.

Prime Minister Boris Johnson told MPs on Wednesday: "I think we're going to have to get used to the idea of vaccinating and then revaccinating in the autumn, as we come to face these new variants."

More Latest News

See more More Latest News

Russia's President Vladimir Putin and Chinese President Xi Jinping

West is facing its 'most serious and dangerous challenge' since World War Two, ex-general warns

Exclusive
UK prisoners could be sent to Poland after new talks.

Polish criminals languishing in UK jails could be deported from British prisons in new deal

Storm Bert is set to bring snow and heavy winds

Brits warned to stock up on food and water as Storm Bert to bring snow, heavy rain and flooding

Zelensky promises 'serious response' following Russia's use of new hypersonic missiles

Zelenskyy promises 'serious response' following Russia's use of new hypersonic missiles

Russia has said it will begin mass production on an "unstoppable" missile.

Russia to begin mass production of 'unstoppable' ballistic missile, Putin warns as Zelenskyy urges 'serious response'

The Met could lose 2,000 officers

Met Police could lose 2,000 officers as force's budget 'may be slashed by £450 million'

Mixed martial arts fighter Conor McGregor (centre) and partner Dee Devlin leave the High Court in Dublin after the personal injury case against him.

Conor McGregor vows to appeal decision after civil jury finds he raped woman in hotel

The new advert was published this week.

Jaguar bosses hit back at ‘vile hatred and intolerance’ following new rebrand

UK prisoners could be sent to Poland after new talks.

'Detailed prison maps' leak on dark web as fears grow of jail escapes

Two detained following Gatwick Airport bomb scare as police 'ramp up presence' in terminal

Two detained following Gatwick Airport bomb scare as police 'ramp up presence' in terminal

Mixed martial arts fighter Conor McGregor (centre) and partner Dee Devlin leave the High Court in Dublin after the personal injury case against him.

Conor McGregor raped woman in hotel, civil jury finds, as she is awarded damages

Donald Trump

Donald Trump hush money sentencing postponed as judge says president-elect can seek dismissal

Hostel at centre of 'mass methanol poisoning' offered free shots in exchange for good reviews, backpacker claims

Hostel at centre of 'mass methanol poisoning' offered free shots in exchange for good reviews, backpacker claims

Parents of British lawyer killed in Laos 'mass methanol poisoning' pay tribute to 'kind and loving daughter'

Parents of British lawyer killed in Laos 'mass methanol poisoning' pay tribute to 'kind and loving daughter'

Queen Camilla to miss Royal Variety as she continues recovery following chest infection

Queen Camilla to miss Royal Variety as she continues recovery following chest infection

Gatwick South Terminal to reopen after bomb scare but passengers still face flight delays and cancellations

Gatwick South Terminal reopens after bomb scare but passengers still face flight delays and cancellations